Close Menu

GSK

NEW YORK (GenomeWeb News) – GlaxoSmithKline today said that it has reached an agreement to acquire the remaining 80 percent of proteomics firm Cellzome that it didn't already own for £61 million ($99 million).

Researchers at GlaxoSmithKline and their collaborators have demonstrated a method for suggesting alternative indications for existing drugs that uses data from genome wide association studies and a repository of drug information.

Canada's Prevention of Organ Failure Centre of Excellence in Vancouver is using C$1.5 million (US$1.5 million) in funding from Genome British Columbia and other groups to develop a molecular test intended to personalize treatment for chronic obstructive pulmonary disease.

By Adam Bonislawski
University of North Carolina researchers have developed a chemical proteomics approach to measure global kinase activity and used it to investigate drug resistance in triple-negative breast cancer.

This article was originally posted March 29.
By Turna Ray

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Epistem today announced a research collaboration with GlaxoSmithKline to use its amplification technology to gain a better understanding of fibrosis.

By Adam Bonislawski
Biodesix said this week that it is collaborating with pharma firm Kadmon on a 620-patient Phase III clinical trial of that company's reversible tyrosine kinase inhibitor KD019.

CLC Bio said this week that it will provide bioinformatics capabilities for a €12 million ($15 million) five-year project funded by the European Commission's Seventh Framework Program that will study mechanisms involved in stem cell differentiation.

This story originally ran on Feb. 1.
French biotech firm Hybrigenics this week reported €6.6 million ($8.7 million) in revenues for 2011, up 45 percent from €4.5 million in 2010.

Pages

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.